[{"address1": "960 San Antonio Road", "city": "Palo Alto", "state": "CA", "zip": "94303", "country": "United States", "phone": "650 516 4310", "website": "https://www.scilexholding.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company has a collaboration with ACEA Therapeutics to Support the Expansion of ZTlido program. Scilex Holding Company is headquartered in Palo Alto, California.", "fullTimeEmployees": 113, "companyOfficers": [{"maxAge": 1, "name": "Dr. Henry H. Ji Ph.D.", "age": 59, "title": "Executive Chairman", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 885430, "exercisedValue": 0, "unexercisedValue": 635079}, {"maxAge": 1, "name": "Mr. Jaisim  Shah", "age": 63, "title": "President, CEO & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 971517, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Ma", "age": 50, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 708783, "exercisedValue": 0, "unexercisedValue": 36559}, {"maxAge": 1, "name": "Dr. Suketu D. Desai Ph.D.", "age": 57, "title": "CTO & Senior VP", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven F. Lincoln J.D.", "title": "General Counsel & Chief Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sumant  Rajendran", "title": "Executive Director of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mike  Ciaffi", "title": "National Sales Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh K. Khemani", "age": 63, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 456820, "exercisedValue": 0, "unexercisedValue": 3799157}, {"maxAge": 1, "name": "Dr. Dmitri V. Lissin M.D.", "age": 64, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 528826, "exercisedValue": 0, "unexercisedValue": 3054720}, {"maxAge": 1, "name": "Ms. Gigi  DeGuzman", "title": "Senior Executive Director & Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.619, "open": 0.63, "dayLow": 0.6251, "dayHigh": 0.6655, "regularMarketPreviousClose": 0.619, "regularMarketOpen": 0.63, "regularMarketDayLow": 0.6251, "regularMarketDayHigh": 0.6655, "beta": 1.15, "forwardPE": -1.6175001, "volume": 668922, "regularMarketVolume": 668922, "averageVolume": 2007349, "averageVolume10days": 1450900, "averageDailyVolume10Day": 1450900, "bid": 0.637, "ask": 0.6648, "bidSize": 1400, "askSize": 1400, "marketCap": 86646240, "fiftyTwoWeekLow": 0.456, "fiftyTwoWeekHigh": 2.63, "priceToSalesTrailing12Months": 1.7045274, "fiftyDayAverage": 0.81692, "twoHundredDayAverage": 1.210865, "currency": "USD", "enterpriseValue": 185333088, "profitMargins": -2.3388, "floatShares": 56661508, "sharesOutstanding": 133920000, "sharesShort": 5396711, "sharesShortPriorMonth": 12159373, "sharesShortPreviousMonthDate": 1728950400, "dateShortInterest": 1731628800, "sharesPercentSharesOut": 0.0403, "heldPercentInsiders": 0.32789, "heldPercentInstitutions": 0.18162, "shortRatio": 1.65, "shortPercentOfFloat": 0.0732, "bookValue": -1.768, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -171532992, "trailingEps": -1.44, "forwardEps": -0.39, "enterpriseToRevenue": 3.646, "enterpriseToEbitda": -1.95, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SCLX", "underlyingSymbol": "SCLX", "shortName": "Scilex Holding Company", "longName": "Scilex Holding Company", "firstTradeDateEpochUtc": 1614954600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ea412020-7b31-3199-90c2-cf75b3e7ae39", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.647, "targetHighPrice": 14.0, "targetLowPrice": 4.0, "targetMeanPrice": 7.625, "targetMedianPrice": 6.25, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 6888000, "totalCashPerShare": 0.052, "ebitda": -95026000, "totalDebt": 106997000, "quickRatio": 0.176, "currentRatio": 0.197, "totalRevenue": 50833000, "revenuePerShare": 0.442, "returnOnAssets": -0.53643, "freeCashflow": 57285248, "operatingCashflow": 12212000, "revenueGrowth": 0.301, "grossMargins": 0.68242997, "ebitdaMargins": -1.86938, "operatingMargins": -0.95436996, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]